Medical Devices Market
Nov 06, 2025
Nexalin Technology Secures Israeli Regulatory Clearance for Gen-2 SYNC 15 mA DIFS™ Neurostimulation System; W&H Medical Launches First U.S.–Cleared Piezo & Drill Combo Console for Rhinoplasty & Facial Surgery; Elevaris Launches CDMO Services and Procedural Needle Offerings in EMEA; Cardinal Health Successfully Acquired Solaris Health; 4WEB Medical Sets a New Standard in Implant-Based Therapy; BD Reaches Key Milestone in AGILITY Trial Evaluating Revello™ Vascular Covered Stent for PAD
Nexalin Technology Announced Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel On October 30, 2025, Nexalin Technology, Inc., a company recognized for its Deep Intracranial Frequency Stimulation (DIFS™) technology, announced that its Gen-2 Console (“SYNC”) 15 mA neurosti...
Read More...
Nov 04, 2025
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Introduction With a growing number of people affected by osteoporosis and other bone-related conditions worldwide, there is an increasing need for accurate and accessible tools to check bone health. One of the most important devices used today is the bone densitometer, which measures bone mineral density (BMD), ...
Read More...
Oct 30, 2025
Zimmer Biomet Wins FDA Breakthrough Status for Iodine-Treated Hip Implant; Terumo Gains U.S. Clearance for OPUSWAVE® System and DualView® Catheter; Medtronic’s Symplicity Spyral RDN Device Added to CMS National Coverage; West Launches Synchrony™ PFS System at CPHI; Emboline Completes U.S. Pivotal IDE Trial Enrollment for Emboliner® Device; Laborie Completes First Procedures in ENDURE 1 Trial with Optilume® Balloon
Zimmer Biomet Announced FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System On October 28, 2025, Zimmer Biomet Holdings, Inc., a global leader in medical technology, announced that the FDA had granted breakthrough device designation for its groundbreaking iodine-treat...
Read More...
Oct 23, 2025
OncoHost Granted New York State Lab Permit, Enabling PROphetNSCLC® Nationwide Access; Onkos Surgical’s ELEOS Proximal Tibia with NanoCept antibacterial surface receives FDA 510(k) clearance; BD’s Simplified At-Home HPV Test to Expand Cervical Cancer Screening Internationally; Oticon’s New Zeal™ Hearing Aid Delivers Discreet Style with Next-Gen AI Sound & Connectivity; Nyra Medical Launches First-in-Human Trial of New Mitral Valve Repair System; Cordis Reveals 12-Month Outcomes from SELUTION SLR DEB Trial
OncoHost Received New York State Laboratory Permit, Expanding Availability of PROphetNSCLC® Precision Oncology Test On October 22, 2025, OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, announced that it had received a laboratory permit from t...
Read More...
Oct 22, 2025
The AI Drug Discovery Revolution: Smarter Science, Faster Therapies, Better Outcomes
The pharmaceutical industry has always been a high-stakes arena, where years of research, billions of dollars, and countless clinical trials culminate in a single therapy reaching patients. Despite tremendous advancements, the traditional drug discovery process remains time-consuming, costly, and fraught with uncer...
Read More...
Oct 16, 2025
Scanogen’s Bloodstream Infection Assay Earns FDA Breakthrough Device Status; Lapsi Health Launches Keikku 2.0; Medtronic BrainSense™ Adaptive DBS Earns 2025 TIME Best Inventions Honor; Photocure Partners with Intelligent Scopes Corporation to Advance AI Integration in Blue Light Cystoscopy; Conformal Medical Expands CONFORM Trial to Europe; Materna Medical Presents Study on At-Home Patient Outcomes: Experienced vs. Naïve Dilator Users
Scanogen Received FDA Breakthrough Device Designation for Rapid Bloodstream Infection Assay On October 15, 2025, Scanogen Inc., a molecular diagnostics innovator developing next-generation infectious disease detection technologies, announced that the U.S. Food and Drug Administration (FDA) granted Breakthr...
Read More...
Oct 15, 2025
Artificial Intelligence in Remote Patient Monitoring: Enabling Continuous, Predictive, and Personalized Care
The convergence of Artificial Intelligence (AI) and Remote Patient Monitoring (RPM) marks a pivotal shift toward predictive, continuous, and patient-centric healthcare. As chronic diseases rise globally, healthcare systems are under pressure to deliver timely, personalized interventions without overburdening hospit...
Read More...
Oct 13, 2025
Digital Twins in the Healthcare Industry
Digital twins are advanced digital replicas of physical systems, processes, or entities that use real-time data, artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT) to simulate, monitor, and predict the behavior of their real-world counterparts. In healthcare, digital twins can rep...
Read More...
Oct 09, 2025
Vektor Medical Receives CE Mark for vMap; Tosoh’s GR01 HbA1c Analyzer Gains FDA 510(k) Clearance; Zimmer Biomet Acquires Monogram Technologies; Olympus Partners with W. L. Gore & Associates to Distribute GORE® VIABIL® Biliary Stent Globally; Medtronic Launches U.S. IDE Study on Hugo™ Robotic Surgery System for Gynecology; Envoy Medical Secures FDA Clearance to Advance Pivotal Trial to Final Stage Following Promising Three-Month Results
Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe On October 7, 2025, Vektor Medical, a leading innovator in cardiac arrhythmia care, received CE Mark approval for its vMap® System, a non-invasive, AI-powered technology that converts standard 12-lea...
Read More...
Oct 08, 2025
Artificial Intelligence in Clinical Trials: Transforming Drug Development Efficiency and Precision
The integration of Artificial Intelligence in clinical trials marks one of the most transformative shifts in modern drug development. As the pharmaceutical industry grapples with rising R&D costs, long trial timelines, and high attrition rates, AI in clinical trials has emerged as a catalyst for optimizing desi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
